Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Wraight
Christoper J. Wraight, Blackburn AU
| Patent application number | Description | Published |
|---|---|---|
| 20090111767 | MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION - The present invention provides compositions and methods for modulating the expression of growth factor gene. In particular, this invention relates to compounds, particularly oligonucleotide compounds, which, in preferred embodiments, hybridize with nucleic acid molecules encoding the Insulin Like Growth Factor I receptor (IGF-I receptor or IGF-IR) and in particular human IGF-IR. Such compounds are exemplified herein to modulate proliferation which is relevant to the treatment of proliferative and inflammatory skin disorders and cancer. It will be understood, however, that the compounds can be used for any other condition in which the IGF-IR is involved including inflammatory conditions. | 04-30-2009 |
Christopher J. Wraight, Blackburn AU
| Patent application number | Description | Published |
|---|---|---|
| 20100093832 | MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION IN CANCER - Provided herein are methods, compounds, and compositions for reducing expression of an IGF-IR mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions that inhibit expression of IGF-IR in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate the tumor or cancer, or a symptom thereof. | 04-15-2010 |
Christopher John Wraight, Blackburn AU
| Patent application number | Description | Published |
|---|---|---|
| 20090286849 | MODULATION OF INSULIN LIKE GROWTH FACTOR I RECEPTOR EXPRESSION - The present invention provides compositions and methods for modulating the expression of growth factor gene. In particular, this invention relates to compounds, particularly oligonucleotide compounds, which, in preferred embodiments, hybridize with nucleic acid molecules encoding the Insulin Like Growth Factor I receptor (IGF-I receptor or IGF-IR) and in particular human IGF-IR. Such compounds are exemplified herein to modulate proliferation which is relevant to the treatment of proliferative and inflammatory skin disorders and cancer. It will be understood, however, that the compounds can be used for any other condition in which the IGF-IR is involved including inflammatory condition. | 11-19-2009 |
Peter Wraight, Princeton Junction, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090139713 | METHOD AND APPARATUS FOR DETECTING WHILE DRILLING UNDERBALANCED THE PRESENCE AND DEPTH OF WATER PRODUCED FROM THE FORMATION - The invention relates to methods and apparatus for determining a downhole parameter in an underbalanced drilling environment which include: selectively activating a first fluid flowing from the formation through a wellbore while under balanced drilled; detecting the activated first fluid, and determining a depth at which said fluid enters the wellbore. | 06-04-2009 |
Peter D. Wraight, Skillman, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110191027 | METHOD AND APPARATUS FOR MEASURING THE VERTICAL SEPARATION OF TWO STATIONS IN A BOREHOLE - A system and method for use in a downhole tool having a fluid density measurement device positioned therein are provided. In one example, the method includes deploying the downhole tool at a first station in a borehole. The downhole tool is moved from the first station to a second station in the borehole. A plurality of fluid density values of fluid within the borehole between the first and second stations are measured using the fluid density measurement device in the downhole tool. The plurality of fluid density values may represent a continuous log of fluid densities between the first and second stations. | 08-04-2011 |